|

Proteogenomic Monitoring and Assessment of Liver Transplant Recipients

RECRUITINGSponsored by Northwestern University
Actively Recruiting
SponsorNorthwestern University
Started2010-04
Est. completion2028-12
Eligibility
Age18 Years+
Healthy vol.Accepted
Locations1 site
View on ClinicalTrials.gov →

NCT01644903

Summary

This study is being done to test blood, urine and tissue samples to see if this can help decide if CKD (Chronic Kidney Disease), AR (Acute Rejection) and HCV (Hepatitis C Virus) can be identified in its early stages. CKD damage to the kidneys, AR and HCV all lower the body's ability to function properly. Early detection of these conditions could assist with successful treatment and possibly lead to less repeat organ transplants.

Eligibility

Age: 18 Years+Healthy volunteers accepted
Inclusion Criteria:

1. Male and female recipients of all races, ≥18 years of age.
2. Patients undergoing primary or subsequent living or deceased donor liver transplantation.
3. Subject and/or guardian must be able to provide informed consent.
4. Subject and/or guardian must be able to comply with the study protocol.

Exclusion Criteria:

1\. Inability or unwillingness of a participant and/or guardian to provide informed consent.

Conditions5

Acute RejectionChronic Kidney DiseaseHepatitis CLiver DiseaseLiver Transplant

Locations1 site

Northwestern Memorial Hospital
Chicago, Illinois, 60611
Misael Villegas, BAmisael.villegas@northwestern.edu

Browse More Trials

Liver Disease trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.